Investor Relations

Corporate Profile

Axonics Modulation Technologies®, Inc., (NASDAQ: AXNX) is a global medical device company focused on the design, development, and commercialization of innovative and minimally invasive Sacral Neuromodulation solutions. Sacral Neuromodulation is a guideline-recommended therapy indicated to treat patients with overactive bladder ("OAB"), fecal incontinence ("FI"), and urinary retention ("UR").

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.